ALPHA TEKNOVA, INC. (TKNO) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $13.22M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $13.17M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $13.12M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $0.00.
ALPHA TEKNOVA, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Current Borrowing Capacity USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Line of Credit Facility, Maximum Month-end Outstanding Amount USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Unused Borrowing Capacity, Amount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $13.22M | $0.00 | $5.52M | $6.62M | $1.10M | (m) | $0.00 | (m) | $13.24M | $13.24M | $196.00K | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $13.17M | $0.00 | $5.52M | $6.62M | $1.10M | (m) | $0.00 | (m) | $13.24M | $13.24M | $210.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $13.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.24M | $224.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | (m) | (m) | $0.00 | $0.00 | $5.52M | $6.62M | $1.10M | (m) | (m) | $13.24M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | (m) | $13.08M | $0.00 | $0.00 | $5.52M | $6.62M | (m) | $0.00 | (m) | $13.24M | $13.24M | $239.00K | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | (m) | $13.03M | $0.00 | $0.00 | $5.52M | $6.62M | (m) | $0.00 | (m) | $13.24M | $13.24M | $252.00K | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | (m) | $12.99M | $0.00 | $0.00 | $5.52M | $6.62M | (m) | $0.00 | (m) | $13.24M | $13.24M | $265.00K | (m) | (m) | (m) | (m) |
| 2025-03-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $4.04M | (m) | $9.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.13M | $191.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | $4.04M | $6.07M | $2.02M | (m) | (m) | (m) | $12.13M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.53M | $10.86M | $10.86M | $3.54M | $6.07M | $2.53M | (m) | (m) | $0.00 | (m) | $12.13M | (m) | $222.00K | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.01M | $12.27M | $12.27M | $3.54M | $6.07M | $2.53M | (m) | (m) | $0.00 | (m) | $12.13M | (m) | $254.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $13.18M | $13.18M | $3.54M | $6.07M | $2.53M | (m) | (m) | $0.00 | (m) | $12.13M | $12.13M | $287.00K | (m) | (m) | (m) | (m) |
| 2024-03-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | $13.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.13M | $145.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $13.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $0.00 | $3.54M | $6.07M | $2.53M | (m) | (m) | (m) | $12.13M | (m) | (m) | (m) | (m) | (m) | $10.00M |
| 2023-09-30 | (m) | $13.17M | $13.17M | $0.00 | $3.54M | $6.07M | $2.53M | (m) | $0.00 | (m) | $12.13M | $12.13M | $159.00K | (m) | (m) | $12.10M | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M |
| 2023-06-30 | $22.16M | $0.00 | $22.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.14M | $308.00K | (m) | (m) | $22.10M | (m) |
| 2023-03-31 | (m) | (m) | $22.04M | $0.00 | $6.46M | $11.07M | $4.61M | (m) | $0.00 | (m) | $22.14M | $22.14M | $-333.00K | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $21.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.14M | $320.00K | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $21.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $0.00 | $0.00 | $4.61M | $6.46M | $11.07M | (m) | (m) | $22.14M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M |
| 2022-10-05 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | $40.13M |
| 2022-10-05 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $16.88M | $0.00 | $0.00 | $5.71M | $8.57M | (m) | $0.00 | (m) | $17.14M | $17.14M | $323.00K | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $16.82M | $0.00 | $0.00 | $5.71M | $8.57M | (m) | $0.00 | (m) | $17.14M | $17.14M | $341.00K | (m) | (m) | (m) | (m) |
| 2022-05-10 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | $40.13M |
| 2022-05-10 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $11.92M | (m) | $4.50M | $6.00M | $1.50M | (m) | (m) | (m) | $12.00M | $12.00M | $204.00K | (m) | (m) | (m) | $5.00M |
| 2021-12-31 | (m) | (m) | $11.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.00M | $220.00K | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $0.00 | $0.00 | $4.50M | $6.00M | $1.50M | (m) | (m) | $12.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M |
| 2021-09-30 | (m) | (m) | $11.83M | $0.00 | $0.00 | $4.50M | $6.00M | $1.50M | $0.00 | (m) | $12.00M | $12.00M | $234.00K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $11.78M | $0.00 | $0.00 | $4.50M | $6.00M | $1.50M | $0.00 | (m) | $12.00M | $12.00M | $249.00K | (m) | (m) | (m) | (m) |
| 2021-03-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | $12.00M | (m) | (m) | (m) |
| 2021-03-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.00M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |